期刊文献+

2005—2007年某医院喹诺酮类抗菌药物利用分析

The Utilization Analysis of Quinolones Used in A Hospital during 2005—2007
下载PDF
导出
摘要 目的评价南京医科大学附属淮安第一医院喹诺酮类药物的利用情况,为临床合理用药提供参考。方法对该院2005—2007年喹诺酮类药物的应用品种、销售金额、用药频度等进行统计分析。结果药品总金额以2005年最高,口服喹诺酮类药物的用药人次数(DDDs)逐年递减,注射用喹诺酮类药物的DDDs逐年递增。口服用培氟沙星和注射用左氧氟沙星在该院的使用频度最高。结论该院使用的喹诺酮类药物品种相对固定,临床应用较为合理,但是注射用喹诺酮类药物的使用量逐年增长,应引起注意。 [Objective]To evaluate the utilization situation of quinolones in Huaian first hospital affiliated to Nanjing medical university, provide references for the clinical rational drug use. [Methods]The Quinolones antibacterials used in our hospital during 2005--2(137 were statistically analyzed in respect of the application variety, consumption sum and DDDs etc. [ Results] The consumption sum of quinolones in 2005 took the first place in the three years. DDDs of oral quinolones decreased year by year, and injectable quinolones increased year by year. Oral pefloxacin and injectable levofloxacin were the most commonly used 2 kinds in our hospital. [ Conclusion] The variety of quinolones used in our hospital is relatively changeless, and the clinical application of that is reasonable. For the application of injectable quinolones increased year by year,it is necessary to pay attention to the management in clinical application.
作者 薛泳
出处 《职业与健康》 CAS 2008年第19期2089-2091,共3页 Occupation and Health
关键词 喹诺酮类药物 用药频度 药物利用 quinolones DDDs Medicine utilization
  • 相关文献

参考文献3

二级参考文献25

  • 1夏培元,肖光夏.细菌对抗生素的耐药性—— 一个必须面对的严重问题[J].中华烧伤杂志,2001,17(2):7-10. 被引量:24
  • 2牛瑞丽,聂岚,李萍,王淑英.我院抗生素使用现状调查及分析[J].中国抗生素杂志,2005,30(2):97-99. 被引量:19
  • 3刘明亮.喹诺酮的演变[J].国外医药(抗生素分册),2006,27(2):69-75. 被引量:16
  • 4Waner-Lanbert drops clinaflozacin[J].Scrip,2000,28:2503-2505.
  • 5First filing for Smith Kline Beecham's gemifloxacin[J].Scrip,1999,(2499):19.
  • 6Zhanel GG,Ennis K,Vercaigne L,et al.A critical review of the fluoroquinolones:focus on respiratory infections[J].Drugs,2002,62(1):13-15.
  • 7Hoshino K, Kitamura A,Morrissey I,et al Comparison of inhibition of Escherichia coli topoisomerase Ⅳ by quinolones with DNA gyrase inhibition[J]. Antimicrob Agents Chemother, 1994, 38(11): 2 623.
  • 8Goldstein FW,Acar JF. Epidemiology of quinolone resi_ stance:Europe and North and South America[J] Dru_ gs, 1995, 49 (suppl 2):36
  • 9Chen DK, McGeer A, De Azavedo JC, et al. Decreased susceptibility of streptococcus pneumoniae to fluoroquinolones in Canada. Canadian bacterial surveillance network[J].N Engl J Med, 1999, 341:233.
  • 10Jones RN, Pfaller MA. Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone,gatifloxacin?:Report from the Sentry antimicrobial surveillance program(1997~ 1999)[J]. Diagnostic Microbilogy and Infectious Disease, 2001,39: 237

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部